Cargando…

Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges

Angiotensin-converting enzyme 2 (ACE2)/Ang II/Ang 1–7 and the apelin/APJ are two important peptide systems which exert diverse effects on the cardiovascular system. ACE2 is a key negative regulator of the renin-angiotensin system (RAS) where it metabolizes angiotensin (Ang) II into Ang 1–7, an endog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kazemi-Bajestani, Seyyed M. R., Patel, Vaibhav B., Wang, Wang, Oudit, Gavin Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359660/ https://www.ncbi.nlm.nih.gov/pubmed/22655211 http://dx.doi.org/10.1155/2012/823193

Ejemplares similares

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

ACE2 and Apelin-13: Biomarkers with a Prognostic Value in Congestive Heart Failure
por: Goidescu, Cerasela Mihaela, et al.
Publicado: (2021)

Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
por: Wang, Wang, et al.
Publicado: (2013)

Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist
por: Kazemi-Bajestani, Seyyed M. R., et al.
Publicado: (2014)

The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)

Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs
por: Wang, Wang, et al.
Publicado: (2019)

The ACE2/Apelin Signaling, MicroRNAs, and Hypertension
por: Chen, Lai-Jiang, et al.
Publicado: (2015)

Effect of apelin on the cardiac hemodynamics in hypertensive rats with heart failure
por: PANG, HUI, et al.
Publicado: (2014)

Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
por: Jia, Hongpeng, et al.
Publicado: (2021)

Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19
por: Oudit, Gavin Y, et al.
Publicado: (2020)

Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression
por: Atluri, Pavan, et al.
Publicado: (2006)

Heart failure and cognitive impairment: Challenges and opportunities
por: Heckman, George A, et al.
Publicado: (2007)

Association of Apelin and Apelin Receptor Polymorphisms With the Risk of Comorbid Depression and Anxiety in Coronary Heart Disease Patients
por: Wang, Ying, et al.
Publicado: (2020)

Chloroquine‐induced cardiomyopathy: a reversible cause of heart failure
por: Yogasundaram, Haran, et al.
Publicado: (2018)

Current Status of Publications of Cardiovascular Interventions in Iran; a PubMed-Based Study
por: Ebrahimi, Mahmoud, et al.
Publicado: (2012)

Resistant Hypertension From Renal Artery Stenosis Leading to Heart Failure With Preserved Ejection Fraction
por: Alyamani, Motasem, et al.
Publicado: (2018)

Cardiac reverse remodelling and health status in patients with chronic heart failure
por: Wang, Kaiming, et al.
Publicado: (2021)

[Pyr(1)]Apelin-13((1–12)) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr(1)]Apelin-13
por: Yang, Peiran, et al.
Publicado: (2017)

Molecular Epidemiology of Heart Failure: Translational Challenges and Opportunities
por: Smith, J. Gustav
Publicado: (2017)

Concept of Atherosclerosis Velocity: Is It a Better Measure of Cardiovascular Risk?
por: Kazemi-Bajestani, Seyyed Mohammad Reza, et al.
Publicado: (2013)

ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity
por: Patel, Vaibhav B., et al.
Publicado: (2016)

Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022)

Screening and Initiating Supportive Care in Patients With Heart Failure
por: Nguyen, Quynh, et al.
Publicado: (2019)

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
por: Altara, Raffaele, et al.
Publicado: (2017)

On Methods for the Measurement of the Apelin Receptor Ligand Apelin
por: Janssens, Peter, et al.
Publicado: (2022)

ACE Inhibition in Heart Failure and Ischaemic Heart Disease
por: Campbell, Duncan J. John
Publicado: (2007)

Effects of Apelin on Left Ventricular-Arterial Coupling and Mechanical Efficiency in Rats with Ischemic Heart Failure
por: Ouyang, Qiufang, et al.
Publicado: (2019)

Angiotensin (1-7) and apelin co-therapy: New strategy for heart failure treatment in rats
por: Hekmat, Ava Soltani, et al.
Publicado: (2020)

The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles
por: Jiang, Yunlu, et al.
Publicado: (2021)

Modulating gut microbial metabolism in heart failure: Opportunities and challenges
por: Tang, W. H. Wilson, et al.
Publicado: (2021)

Immunotherapies targeting tumor vasculature: challenges and opportunities
por: Dianat-Moghadam, Hassan, et al.
Publicado: (2023)

Lipid Clinics Are Urgently Required in the Iranian Public Health System
por: Ghayour-Mobarhan, Majid, et al.
Publicado: (2010)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
por: Putko, Brendan N., et al.
Publicado: (2014)

Apelin as a new therapeutic target for COVID-19 treatment
por: Park, J, et al.
Publicado: (2022)

The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
por: Berezin, Alexander A., et al.
Publicado: (2022)

A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension
por: Rozwadowski, Jan, et al.
Publicado: (2022)

Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer
por: Feng, Meiyan, et al.
Publicado: (2016)

Elabela-Apelin Receptor Signaling Pathway is Functional in Mammalian Systems
por: Wang, Zhi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mpdl9bejdf8stvto2enqmmb4q2